D
DaVita Inc. (DVA)
NYQ – Real vaqt narxi. Valyuta: USD
200.54
+1.61 (0.81%)
Yopilishda: May 12, 2026, 4:00 PM EDT
199.38
-1.16 (-0.58%)
Bozor oldidan: May 13, 2026, 7:41 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NYQ – Real vaqt narxi. Valyuta: USD
200.54
+1.61 (0.81%)
Yopilishda: May 12, 2026, 4:00 PM EDT
199.38
-1.16 (-0.58%)
Bozor oldidan: May 13, 2026, 7:41 AM EDT
DaVita Inc. Qo'shma Shtatlarda surunkali buyrak etishmovchiligidan aziyat chekayotgan bemorlar uchun buyrak dializi xizmatlarini taqdim etadi. Kompaniya buyrak dializi markazlarini boshqaradi va ambulator dializ markazlarida tegishli laboratoriya xizmatlarini ko'rsatadi. U shuningdek, ambulator, kasalxonada statsionar va uyda gemodializ xizmatlarini taklif qiladi; dializ uchun muntazam laboratoriya testlarini va buyrak etishmovchiligining terminal bosqichi (ESRD) bemorlari uchun shifokor buyurgan boshqa laboratoriya testlarini o'tkazadigan klinik laboratoriyalarni boshqaradi; va ambulator dializ markazlariga boshqaruv va ma'muriy xizmatlarni ko'rsatadi. Bundan tashqqari, kompaniya xavfga asoslangan va boshqa integratsiyalashgan parvarishlash sxemalari doirasida bemorlarga integratsiyalashgan parvarish va kasallikni boshqarish xizmatlarini taklif etadi; klinik tadqiqot dasturlari; shifokor xizmatlari; va buyrakni parvarish qilishning keng qamrovli xizmatlari. Bundan tashqari, u transplantatsiya dasturiy ta'minoti biznesi bilan shug'ullanadi. Kompaniya ilgari DaVita HealthCare Partners Inc. nomi bilan tanilgan va 2016-yil sentyabr oyida DaVita Inc. nomini o'zgartirgan. DaVita Inc. 1994-yilda tashkil etilgan va shtab-kvartirasi Denver, Koloradoda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Jeffrey Allen Giullian | Chief Medical Officer of Kidney Care |
| Dr. Partha Das M.D., M.Sc. | Chief Medical Officer of DaVita International |
| Mr. David P. Maughan | Chief Operating Officer of DaVita Kidney Care |
| Mr. James O. Hearty | Chief Compliance Officer |
| Mr. Javier J. Rodriguez | CEO & Executive Director |
| Mr. Joel Ackerman | CFO & Treasurer |
| Mr. Misha Palecek | Chief Transformation Officer of U.S. Kidney Care Business |
| Ms. Kathleen Alyce Waters | Chief Legal & Public Affairs Officer |
| Ms. Stephanie Hendrickson | Chief People Officer |
| Nic Eliason | Group Vice President of Investor Relations |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-05 | 10-Q | dva-20260331.htm |
| 2026-04-22 | DEF 14A | dva-20260422.htm |
| 2026-02-11 | 10-K | dva-20251231.htm |
| 2026-02-02 | 8-K | dva-20260202.htm |
| 2025-11-25 | 8-K | dva4564821-8k.htm |
| 2025-10-29 | 10-Q | dva-20250930.htm |
| 2025-08-20 | 8-K | dva-20250820.htm |
| 2025-08-05 | 8-K | dva-20250805.htm |
| 2025-08-05 | 10-Q | dva-20250630.htm |
| 2025-07-17 | 8-K | d75954d8k.htm |